A phase I study of YHI-1001 in patients with solid tumors
Phase of Trial: Phase I
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Resminostat (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Yakult Honsha
- 06 May 2014 Status changed from recruiting to completed according to a 4SC media release.
- 13 Jul 2012 New trial record
- 15 May 2012 The first patient has been treated, according to a media release from 4SC.